MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication
an InvestmentWires' Publication
|
|
MutualFundWire.com
The insiders' edge for 40 Act industry executives!
an InvestmentWires' Publication |
|
Wednesday, April 9, 2003 Federated Adds K-class, to Expand Investment Focus Federated Investors is now offering K class shares for seven of its most popular mutual funds in response to the growth of the small and mid-sized defined contribution plan market, and as part of its larger push into the investment-only, management space. The K shares, which pay an annual trail of 50 basis points and an additional 25 basis points in recordkeeping, or sub TA, fees, were launched this past Monday to better meet demand from third-party administrators, banks and brokerages that serve the $2-10 million DC plan segment, said Christopher T. Fives, senior vice president and director of Retirement Plan Sales at Federated. Fives noted that the K shares fill the gap between Federated's existing A-class, which targets the $10 million-plus segment, and C-class shares aimed at the under $2 million retirement plan space. Fives told the 401kWire.com that the C shares pay an annual trail of 100 basis points, while the A shares payout 25 basis points. Federated's A and C classes each pay 10 basis points in sub-TAs. Moreover, Fives noted that Federated is looking to expand its investment-management efforts in the separately-managed account and defined benefit areas, particularly as additional markets to place its funds. The seven Federated funds carrying the K shares are Capital Appreciation, a blend fund offering growth and value investing styles; Kaufmann Fund, a small- to mid-cap growth fund; American Leaders Fund, a large-cap value vehicle; Max-Cap Index Fund, a large-cap fund; Stock and Bond Fund, a conservative offering; Total Return Bond; and U.S. Government Securities (2-5 Years). Separately, Standard & Poor's on Tuesday said it will add Federated Investors to its benchmark 500 stock index to replace Pharmacia Corp., the drugmaker being bought by Pfizer. Printed from: MFWire.com/story.asp?s=4925 Copyright 2003, InvestmentWires, Inc. All Rights Reserved |